Drexel Morgan & Co. Bristol Myers Squibb CO Transaction History

Drexel Morgan & Co.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $365,021 - $397,508	-5,896 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $593 - $667	-10 Reduced 0.17%	5,896 $372,000
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $151,155 - $167,500	-2,632 Reduced 30.83%	5,906 $356,000
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $35,728 - $51,921	-770 Reduced 8.27%	8,538 $476,000
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $98 - $128	2 Added 0.02%	9,308 $597,000
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $342 - $405	8 Added 0.09%	9,306 $472,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,298	9,298 $518,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Drexel Morgan & Co., based on Form 13F filings with the SEC.

Stay updated on Drexel Morgan & Co. with notifications on news.